Science Explorer Interactive view Map

Meiji Pharma Spain

Research works
38
▼ 23% vs 2013–17
Citations
449
11.9 per fractional work
Top-10% rate
7.3%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Meiji Pharma Spain is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.75× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.21× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.44× its world share, 0 worksImmunology and Micro…Neuroscience: 0.89× its world share, 0 worksNeuroscienceEngineering: 0.84× its world share, 1 worksEngineeringEnvironmental Science: 0.39× its world share, 0 worksEnvironmental ScienceHealth Professions: 3.84× its world share, 1 worksHealth ProfessionsMedicine: 2.46× its world share, 3 worksMedicineNursing: 2.36× its world share, 0 worksNursingPsychology: 2.85× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Health Professions, 3.8×. Every wedge is a field page.

Which keywords describe research at Meiji Pharma Spain?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Clinical Practice Guidelines, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Inflammation, Antibiotic Pharmacokinetics and Critically Ill Patients.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Epidemiology9▲ 5.8×16 topics
  2. Antimicrobial Resistance6▲ 68×5 topics
  3. Clinical Practice Guidelines4▲ 17×5 topics
  4. Inflammation3▲ 3.8×14 topics
  5. Community-Acquired Pneumonia3▲ 189×1 topic
  6. Pneumococcal Conjugate Vaccine3▲ 189×1 topic
  7. Oxidative Stress3▲ 4.0×12 topics
  8. Antibiotic Pharmacokinetics2▲ 138×1 topic
  9. Climate Change2▲ 2.3×7 topics
  10. Critically Ill Patients2▲ 138×1 topic
  11. Nutrition2▲ 11×5 topics
  12. Remote Sensing2▲ 4.2×2 topics
  13. Risk Assessment2▲ 7.5×3 topics
  14. Antibiotic Resistance2▲ 11×2 topics
  15. GIS-based Modeling2▲ 53×2 topics
  16. Clinical Management1▲ 19×2 topics
  17. Pathogenesis1▲ 6.7×3 topics
  18. Hazard1▲ 64×1 topic
  19. Landslide1▲ 64×1 topic
  20. ESKAPE Pathogens1▲ 60×1 topic
  21. Multidrug-Resistant Bacteria1▲ 60×1 topic
  22. Glacial Cycles1▲ 26×1 topic
  23. Obesity1▲ 3.9×5 topics
  24. Paleoclimatology1▲ 22×1 topic
  25. Regeneration1▲ 17×2 topics
  26. Virulence Factors1▲ 16×3 topics
  27. Aging1▲ 5.2×3 topics
  28. Residential1▲ 159×1 topic
  29. Segregation1▲ 34×1 topic

Which research topics does Meiji Pharma Spain publish most on?

By volume in 2022–2025: Sleep and related disorders, Health and Lifestyle Studies, Osteoarthritis Treatment and Mechanisms and Antimicrobial Resistance in Staphylococcus.

  1. 1 Sleep and related disorders Experimental and Cognitive Psychology 0 works
  2. 2 Health and Lifestyle Studies General Health Professions 0 works
  3. 3 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
  4. 4 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
  5. 5 Total Knee Arthroplasty Outcomes Surgery 0 works
  6. 6 Pneumonia and Respiratory Infections Epidemiology 0 works
  7. 7 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  8. 8 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
  9. 9 Iron Metabolism and Disorders Hematology 0 works
  10. 10 Diabetic Foot Ulcer Assessment and Management Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.8%not open46.2%

World: 28% of research is openly available.

with international co-authors38.2%domestic only61.8%

World: 19% is written across borders.

How has Meiji Pharma Spain's research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Alcalá de Henares

All research institutions in Alcalá de Henares

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.